Introduction {#s0005}
============

Niemann--Pick C1 (NPC1) is a multipass transmembrane protein residing in late endosomes and lysosomes ([@bb0090; @bb0100; @bb0160]) and is essential to prevent the storage of cholesterol in those compartments ([@bb0155; @bb0180]). Working with NPC2, NPC1 mediates the egress of LDL-derived cholesterol from the endolysosomal compartment ([@bb0220]) by a mechanism(s) not yet fully characterized, although great progress is being made ([@bb0055; @bb0110]). The widely accepted model is that NPC2 binds free cholesterol after lysosomal hydrolysis of LDL cholesteryl esters and transfers it to NPC1, which mediates the exit of cholesterol from lysosomes ([@bb0065; @bb0120]). Mutations of *NPC1* and *NPC2* genes in our species are associated with Niemann--Pick disease type C (95% and 5% of patients, respectively) ([@bb0255]).

A prominent feature of NPC1 disease is the massive loss of cerebellar Purkinje cells (PCs) ([@bb0095; @bb0165]). A similar feature is also observed in several mouse models of NPC1 disease, in which PC degeneration and loss begin at 28--40 days of postnatal age (PN28--40) and become very pronounced at PN60 ([@bb0095]). Several approaches, including chimeric mice, conditional knock-out models and various neuron/glial-specific transgenic rescue experiments ([@bb0040; @bb0080; @bb0300; @bb0305]) have been used to investigate the contribution of specific cell types to NPC1 neuropathology. Using chimeras of *Npc1*^−/−^ and normal cells, it was proposed that *Npc1*^−/−^ PC death is a cell-autonomous property ([@bb0115]), occurring even when PCs are surrounded by wild-type Bergmann glia (BG). Moreover, wild-type PCs survive well although surrounded by *Npc1*^−/−^ BG ([@bb0115]). Despite these observations, the role astroglial cells exert in NPC neuropathology is still controversial. Exploiting a neuron-glia co-culture system, it was observed that *Npc1*-deficient astrocytes do not support neurite growth as efficiently as wild-type astrocytes do ([@bb0050]). A transgenic line re-expressing *Npc1* from a glial fibrillary acidic protein promoter in *Npc1^−/−^* mice displayed lower levels of neuronal cholesterol accumulation and lived longer ([@bb0305]). On the other hand, the transgenic re-expression of *Npc1* in neurons or in astrocytes of *Npc1^−/−^* mice led to the conclusion that neuronal rescue only reduced neurological symptoms ([@bb0135]). Moreover, the presence of a conditional *Npc1* null allele in neurons was shown to mostly recapitulate the neuropathology typical of NPC ([@bb0300]), but the deletion in oligodendrocytes resulted in the impairment of myelin formation and maintenance ([@bb0295]).

Because neuropathological signs first appear in 5-week-old *Npc1*^−/−^ mice, it is currently believed that developmental processes are not affected by the loss-of-function of the *Npc1* gene. However, a study by [@bb0030] has shown that 2-week-old *Npc1*^−/−^ mice display a significant level of microglia activation in several brain areas, including cerebellum. Microglia regulate neuronal proliferation and differentiation ([@bb0025]), raising the question as to whether these processes may be influenced by microglia activation. At 2 weeks of age, in fact, cerebellar cortical development is still ongoing with active granule neuron (GN) proliferation/differentiation/migration and PC dendritic expansion, making the study of postnatal cerebellar development in *Npc1*^−/−^ mice worthy of further investigation.

Among cerebellar cells, GNs have been studied little in murine models of NPC1 disease, perhaps because their development takes place during the first 3 weeks of postnatal life ([@bb0010; @bb0235; @bb0270]), whereas signs of cerebellar pathology occur in older mice. Indeed, GNs are progressively generated from E18.5 until PN16.5 from a progenitor layer covering the cerebellar surface, which is named the external granule layer (EGL) ([@bb0225]). During early postnatal development, the coexistence of two GN precursor populations splits the EGL into two sub-regions, the outer EGL (containing mitotic cells; oEGL) and the inner EGL (containing post-mitotic cells; iEGL). GN precursors forming the oEGL and iEGL can be distinguished from each other by the expression of different protein markers, such as PCNA for mitotic and p27Kip1 for post-mitotic cells ([@bb0020; @bb0145]). Besides these two GN populations, an additional one, named "intermediate progenitors" and residing in a region of overlap between the oEGL and iEGL, has been recently characterized ([@bb0285]).

At around the time of birth some GNs exit from the cell cycle and migrate inward to form the internal granule layer (IGL) that represents their final destination, determining the gradual disappearance of the EGL ([@bb0010]). GN proliferation in postnatal cerebellum EGL is sustained by various factors, including Sonic Hedgehog (Shh) secreted by PCs ([@bb0060; @bb0250; @bb0275]) and several microglia-released growth factors that activate the Notch signaling pathway ([@bb0150]). Upon exit from the cell cycle, GNs migrate radially along the Bergmann glia and through the PC layer to reach the internal granule layer (IGL) ([@bb0005]) where they contribute to the formation of cerebellar glomeruli, a complex of synapses with mossy fiber endings converging on GN dendrites ([@bb0125]). Mossy fiber inputs are then transmitted to PCs *via* synaptic contacts between GN parallel fibers and PC dendrites.

Even though a prominent effect of *Npc1* loss-of-function on GN development has not been reported, membranous inclusions in the cytoplasm of these cells were observed by electron microscopy in cerebella of 5-week-old *Npc1*^−/−^ mice ([@bb0245]). Moreover, in a more recent study, the IGL of a *Npc1*^−/−^ cat was found to be thinner compared to that of wild-type controls, opening the possibility that GNs were generated in a lower number during postnatal cerebellar development or died because of an increased level of apoptosis ([@bb0260]). An additional line of evidence enlightening the possible contribution of a GN defect to NPC neuropathology derives from a recent study showing that the synaptic transmission from parallel fibers to PCs is increased and that long-term depression (LTD) is deficient in 3-week-old *Npc1*^−/−^ mice ([@bb0240]).

In this study we show that the EGL of *Npc1*-deficient mice has fewer GNs and persists for a shorter time compared to age-matched wild-type mice and that a single treatment with hydroxypropyl-β-cyclodextrin (HPBCD) at PN7 re-establishes the normal EGL thickness/GN number in *Npc1^−/−^* cerebella. We also show that the level of *Shh* transcripts of *Npc1*^−/−^ cerebella undergoes a significant reduction during the second post-natal week, likely affecting the proliferation of GN precursors. To our knowledge, these findings provide the first evidence of a developmental GN defect in *Npc1*^−/−^ mice, enlarging the perspective for future studies on the molecular mechanisms that underlie NPC1 disease.

Materials and methods {#s0010}
=====================

Animals and treatments {#s0025}
----------------------

*Npc1^−/−^* mice on the BALB/cJ background were generated by mating heterozygous animals. Genotypes were identified from tail DNA by PCR as described ([@bb0130]). Treatment with HPBCD (Sigma Aldrich, Milan, Italy) was performed in 7-day-old mice by a subcutaneous injection of 4 g HPBCD/kg body weight. BrdU labeling was achieved by intraperitoneal injection with 5-bromodeoxyuridine (60 mg BrdU/g body weight, Sigma Aldrich Inc., Milan, Italy). Mice were maintained in our animal facility in accordance with Sapienza University guidelines for the care and use of laboratory animals. Experimental protocols and related procedures were approved by the Italian Ministry of Public Health.

Histology and immunohistochemistry {#s0030}
----------------------------------

*Npc1^+/+^* and *Npc1^−/−^* mouse brains of postnatal days 11, 14 and 28 (PN11--28), either treated or untreated with HPBCD, were quickly dissected, fixed overnight at 4 °C in 4% PFA in 0.1 M phosphate buffer (PBS), dehydrated and embedded in Paraplast Plus Tissue Embedding Medium (Società Italiana Chimici, Rome; Italy). Paraffin tissue blocks were serially sectioned (slice thickness 8 μm), obtaining parasagittal sections that were mounted on Superfrost Excell adhesion slides (Thermo Scientific, Milan, Italy), de-waxed with xylene, re-hydrated and washed in PBS. For gross morphology of cerebellar lobules, sections encompassing the middle of the cerebellar vermis were stained with Nuclear Fast Red Solution (0.1% nuclear fast red, 5% aluminum sulfate; Sigma Aldrich Inc., Milan, Italy) for 30 min. Determination of the region of interest (ROI) in histological sections for area measurements (total cerebellum, total lobule IV/V, and IGL and ML of lobule IV/V) was independently performed by two investigators on three consecutive mid-sagittal sections of at least five mice per group, using ImageJ NIH software version 1.47v (National Institutes of Health, Bethesda, MD). Images to be compared were carefully selected paying attention that they were the closest possible to the parasagittal position, as inferred by the deeper white matter tracts matching very well in each image. The region of interest (ROI) in each section was outlined using the "selection brush" or the "polygon tool", obtaining similar results.

To determine the number of GN cells, sections from PN11 and PN14 mice were stained with 0.5 μg/mL Hoechst (Hoechst-33258, Invitrogen, Milan, Italy) for 4 min. To assess GN proliferation, brains were dissected from *Npc1^+/+^* and *Npc1^−/−^* mice, either treated or untreated with HBCD and that had received a single BrdU injection at PN10, PN12 and PN14, and processed as described above, obtaining parasagittal sections to be stained with anti-BrdU antibodies. Epitopes were unmasked by heating sections 2 × 5 min in 0.1 M citric acid, pH 6.0, in a microwave oven. Tissue permeabilization was achieved by incubation in trypsin solution (0.05% trypsin, 0.1% CaCl~2~ in water) for 15 min at room temperature (RT) and then in 2 M HCl for 30 min. After washing with PBS, sections were incubated overnight at 4 °C with a monoclonal anti-BrdU antibody (Immunological Science, Rome, Italy; 1:100 dilution in PBS supplemented with 0.5% Tween 20), and then for 45 min with an anti-mouse IgG antibody (Alexa Fluor-555 InVitrogen, Milan, Italy; 1:1500 final dilution). Sections were finally counterstained with Hoechst-33258, mounted with Prolong Gold Antifade Reagent and analyzed with an epifluorescence Zeiss microscope. For quantification of BrdU-immunopositive cells, ROIs were randomly selected from bases and crowns of the anterior (between lobules II and III), middle (between lobules VI and VII) and posterior (between lobules IX and X) lobules of 4 cerebella for each developmental stage. The total number of cells in each region was calculated by determining the number of nuclei based on Hoechst staining.

For p27Kip1 immunodetection, histological sections were subjected to unmasking and permeabilization procedures similar to those described for BrdU immunostaining. Following an incubation with 5% hydrogen peroxide for 15 min to inhibit endogenous peroxidase, sections were incubated with a buffer made of 6% goat serum and 0.3% Triton-X100 in PBS for 30 min to block non-specific binding. Immunohistochemistry was performed using the avidin--biotin horseradish peroxidase complex (ABC) method. Briefly, sections were incubated with rabbit monoclonal primary antibody against p27Kip1 (Epitomics, Burlingame, CA, USA; 1:75 final dilution) overnight at 4 °C, washed 3 times with PBS, and stained using the rabbit Vectastain Elite ABC Kit (Vector Laboratories Inc., Burlingame, CA, USA) first, allowing the specific ABC complex development, and then the DAB Peroxidase Substrate Kit (Vector Laboratories Inc., Burlingame, CA, USA), according to the protocol supplied by the manufacturer. Nuclear counterstaining was performed by incubating sections with 0.5% methyl green solution (0.5% methyl green, 0.1 M sodium acetate buffer in water, pH 4.2) for 5 min at 60 °C.

*In situ* Terminal deoxynucleotidyl transferase(TdT)-mediated dUTP Nick-End Labeling (TUNEL) {#s0035}
--------------------------------------------------------------------------------------------

Cell death in the developing cerebellum of *Npc1^+/+^* and *Npc1^−/−^* mice was assessed by the *in situ* TUNEL method selective for apoptotic cells. Sections were covered with 20 μg/mL Proteinase K for 1 h at 37 °C to permeabilize the tissue. After 2 washes in PBS for 5 min each, sections were incubated with 100 μL Tunel Equilibration Buffer for 5 min and then with 100 μL TUNEL Reaction Buffer containing 2% TdT enzyme for 2 h at 37 °C (Immunological Science, Rome, Italy). Sections were washed 3 times for 5 min each in PBS containing 0.1% Triton X-100 and 5 mg/mL BSA. Slides were then stained with 0.5 μg/mL Hoechst (Hoechst-33258, Invitrogen, Milan, Italy) for 4 min, mounted with Prolong Gold Antifade Reagent (InVitrogen, Milan, Italy) and examined using an epifluorescence Zeiss microscope. Images were acquired with a Cool Snap K4 Photometrics camera.

RNA preparation and real-time RT-PCR {#s0040}
------------------------------------

Total RNA was extracted from PN8, PN12, *Npc1^+/+^* and *Npc1*^−/−^ cerebella, either treated or untreated with HPBCD, using TRIzol (Life technologies, CA, USA) and treated with DNase I (Ambion, Life technologies, CA, USA) for 15 min at 37 °C to remove genomic DNA. cDNA was synthesized using the GoScript Reverse Transcription System (Promega, WI, USA) following the protocol supplied by the manufacturer. Real-time PCR was performed using QuantiFast Sybr Green PCR Master Mix (Qiagen Inc., CA, USA) with the following cycling conditions: 95 °C for 10 min, then 35 cycles of 95 °C for 10 s and 62 °C for combined annealing/extension for 40 s. The QuantiFast PCR primers were: Mm_Shh_1\_SG Cat No. QT00122479 (*Shh*), Mm_Actb_2\_SG Cat No. QT01136772 (*β-actin*), and Mm_Rps16_QT0009256 (S16 ribosomal protein). The level of *Shh* gene was normalized to the expression level of the housekeeping genes *β-actin* and *rps16.*

Statistics {#s0045}
==========

Statistical analyses were performed using GraphPad Prism version 5.0d (GraphPad, La Jolla, CA). Data are expressed as mean values ± SEM. Statistically significant differences were analyzed using one-way ANOVA followed by Bonferroni\'s post hoc test. *p* values less than 0.05 were considered significant.

Results {#s0015}
=======

Cerebellar lobule size is reduced in Npc1^−/−^ mice and is rescued by a single HPBCD injection {#s0050}
----------------------------------------------------------------------------------------------

During postnatal development, the increase of cerebellum volume is largely due to the proliferation of GNs at the level of the EGL ([@bb0225]). In the mouse, GN proliferation is mainly regulated by Shh expression and activity that, thereby, determine final cerebellar size and shape ([@bb0205; @bb0250; @bb0265; @bb0275]). Reasoning that cholesterol is of particular relevance for both Shh signal generation and transduction in receiving cells, we analyzed the size and anatomy of cerebellar lobules in PN28 *Npc1^−/−^* and age-matched *Npc1^+/+^* mice. At this time, the cerebellar cortex has already achieved the conformation of the adult, consisting of a so-called molecular layer (ML), mainly formed by fibers with few scattered cells, and the internal granule layer (IGL), mainly containing GNs. Gross morphological analysis revealed that the overall cerebellar size of *Npc1^−/−^* mice was reduced compared to that of age-matched wild-type mice ([Figs. 1](#f0005){ref-type="fig"}A,B). To quantify such reduction in size, the total areas of parasagittal sections of wild-type, *Npc1^−/−^* and HBPCD-treated *Npc1^−/−^* cerebella were measured after nuclear fast red staining, observing that *Npc1^−/−^* mice displayed a 20% reduction and that a single subcutaneous injection of HPBCD at PN7 largely rescued this phenotype ([Figs. 1](#f0005){ref-type="fig"}B,C).

Parasagittal sections encompassing the middle part of the entire cerebellar vermis were also useful for visualizing the morphology of cerebellar lobules, showing that both fissuration and lobule/sublobule formation were normal and that the final step of lobule growth was actually impaired by *Npc1* loss-of-function. This feature extended to all lobules without graded antero-posterior or postero-anterior patterns ([Fig. 2](#f0010){ref-type="fig"}A). To further investigate the issue of cerebellar size reduction, total, IGL and ML areas of a representative lobule were determined, as performed by [@bb0175]. Lobule IV/V was chosen because of its conspicuous length and less elaborate shape, making area measurements more reliable. These analyses indicated that the total area of lobule IV/V displayed a 24% size reduction and that IGL and ML displayed a similar extent of size reduction, 26% and 20%, respectively ([Figs. 2](#f0010){ref-type="fig"}A,B). IGL:ML area ratios appeared not to vary significantly in each group (wild-type mice, 0.66; *Npc1^−/−^* mice, 0.62; HPBCD-treated *Npc1^−/−^* mice, 0.69; *p* = 0.4), leading to the conclusion that *Npc1* loss-of-function determines an "in-proportion" size reduction, which is in agreement with the normally appearing, yet smaller cerebellum of *Npc1^−/−^* mice. HPBCD treatment fully rescued the reduction in size, even determining a slight size increase.

Npc1^−/−^ mice display a shorter-lasting EGL {#s0055}
--------------------------------------------

Starting at around the time of birth, some GN precursors exit the cell cycle and begin to differentiate into mature GNs ([@bb0010]). Then post-mitotic GNs migrate through the single row of PCs to reach the IGL. This determines the gradual thinning and disappearance of EGL by the third post-natal week. We investigated the issue of reduced cerebellar lobule size of *Npc1^−/−^* by determining the EGL thickness in parasagittal sections obtained from cerebella of mice at increasing post-natal days of development, namely PN8, PN11 and PN14. The EGL was visualized by staining GN nuclei with Hoechst, while the number of GNs was determined by counting nuclei in randomly selected regions of 100 μm^2^ each ([Fig. 3](#f0015){ref-type="fig"}). This analysis showed that EGL thickness and GN densities were similar in PN8 (not shown) and PN11 *Npc1^+/+^* and *Npc1^−/−^* mice, whereas in PN14 *Npc1^−/−^* mice, the EGL was mostly undetectable compared to that of age-matched *Npc1^+/+^* mice. Indeed, only a few scattered GNs, not even forming a single row of cells, were observed in both crowns and fissures of either the anterior or posterior lobules of *Npc1^−/−^* mice. In agreement with the rescuing effect HPBCD had on cerebellar lobule size, a single HPBCD injection at PN7 doubled the number of GNs in the EGL of PN14 *Npc1^−/−^* mice.

Loss of Npc1 function results in GN proliferation defect {#s0060}
--------------------------------------------------------

The finding that *Npc1^−/−^* mice displayed a shorter-lasting EGL compared to age-matched *Npc1^+/+^* mice despite the presence of normal EGL thickness/GN numbers until PN11, suggested that the clock driving the proliferation of GN precursors was somehow dysregulated in *Npc1^−/−^* mice, leading these cells to prematurely exit from the cell cycle. Alternatively, an increase in the number of cells undergoing apoptosis could also account for the reduction of GNs forming the EGL. In either case, the time window in which these events take place likely corresponded to very late stages of GN mitotic expansion *i.e.*, between PN11 and PN14.

To address these questions, we determined the number of cells incorporating BrdU 20 h after a single BrdU injection of PN10, PN12 or PN14 *Npc1^+/+^* and *Npc1^−/−^* mice, either untreated or treated with HPBCD. While similar in PN10 mice, the number of BrdU-positive cells in both crowns and fissures of the anterior cerebellar lobules was significantly reduced in PN12 and PN14 *Npc1^−/−^* mice compared to age-matched *Npc1^+/+^* mice. In posterior cerebellar lobules a reduction of BrdU-positive cells was only observed in fissures of PN14 *Npc1^−/−^* mice.

HPBCD treatment led *Npc1^−/−^* mice to display a number of BrdU-positive cells similar to that of *Npc1^+/+^* mice ([Fig. 4](#f0020){ref-type="fig"}). The possibility of apoptosis was then investigated by analyzing midsagittal sections of PN12, PN14 and PN28 mouse cerebella with TUNEL. This assay showed that few TUNEL-positive cells were observed in cerebella of *Npc1^+/+^* and *Npc1^−/−^* mice, either treated or untreated with HPBCD ([Figs. 5](#f0025){ref-type="fig"}A,B). The number of TUNEL-positive cells decreased with age but neither varied significantly between *Npc1^+/+^* and *Npc1^−/−^* nor was affected by the treatment with HPBCD ([Fig. 5](#f0025){ref-type="fig"}B). Noteworthy, TUNEL-positive cells were scarcely observed in the EGL of either *Npc1^+/+^* or *Npc1^−/−^* PN12 and PN14 mice, with only 1--2 TUNEL-positive cells *per* lobule. These observations indicate that increased cell death is not the primary cause of the reduction in GN number, instead suggesting an earlier exit of these cells from the mitotic cycle as a more likely possibility. This possibility was further strengthened by the observation that *Shh* transcript levels were significantly reduced in cerebella of PN8 and PN12 *Npc1^−/−^* compared to age-matched *Npc1^+/+^* mice and returned to normal levels after HPBCD treatment ([Fig. 6](#f0030){ref-type="fig"}).

Loss of Npc1 function results in disorganized cellular architecture of the EGL {#s0065}
------------------------------------------------------------------------------

As stated in the [Introduction](#s0005){ref-type="sec"} section, under normal developmental conditions a sharp boundary separates the population of mitotically-active p27Kip1-negative GNs forming the outer EGL from the p27Kip1-positive post-mitotic GNs forming the inner EGL. Accordingly, when we performed p27Kip1 immunostaining coupled to a counterstaining of nuclei with methyl green on PN8 cerebella, this boundary was easily identified in both *Npc1^+/+^* and *Npc1^−/−^* mice ([Fig. 1SM](#ec0005){ref-type="supplementary-material"}). By contrast, p27Kip1 immunostaining of PN11 cerebella of *Npc1^−/−^* mice revealed that the stereotyped and ordered EGL architecture in the inner and outer sub-regions markedly differed between *Npc1^+/+^* and *Npc1^−/−^* mice ([Fig. 7](#f0035){ref-type="fig"}). Indeed, p27Kip1-immunopositive cells were scattered along the entire EGL and apparently represented the largest population of GNs. Therefore, at PN11, the niche of mitotically active, p27Kip1-negative GNs (identifying the oEGL) of *Npc1^+/+^* mice is strongly reduced or even lost in *Npc1^−/−^* mice. Interestingly, HPBCD treatment of *Npc1^−/−^* mice also reduced the fraction of p27Kip1-immunopositive cells but did not fully re-established the sharp boundary between the outer and inner EGLs ([Fig. 7](#f0035){ref-type="fig"}). A scheme comparing GN proliferation in *Npc1^+/+^* and *Npc1^−/−^* EGLs, based on the findings of our study, is shown in [Fig. 8](#f0040){ref-type="fig"}.

As stated in the [Introduction](#s0005){ref-type="sec"} section, under normal developmental conditions a sharp boundary separates the population of mitotically-active p27Kip1-negative GNs forming the outer EGL from the p27Kip1-positive post-mitotic GNs forming the inner EGL. Accordingly, when we performed p27Kip1 immunostaining coupled to a counterstaining of nuclei with methyl green on PN8 cerebella, this boundary was easily identified in both *Npc1^+/+^* and *Npc1^−/−^* mice (Fig. 1SM). By contrast, p27Kip1 immunostaining of PN11 cerebella of *Npc1^−/−^* mice revealed that the stereotyped and ordered EGL architecture in the inner and outer sub-regions markedly differed between *Npc1^+/+^* and *Npc1^−/−^* mice ([Fig. 7](#f0035){ref-type="fig"}). Indeed, p27Kip1-immunopositive cells were scattered along the entire EGL and apparently represented the largest population of GNs. Therefore, at PN11, the niche of mitotically active, p27Kip1-negative GNs (identifying the oEGL) of *Npc1^+/+^* mice is strongly reduced or even lost in *Npc1^−/−^* mice. Interestingly, HPBCD treatment of *Npc1^−/−^* mice also reduced the fraction of p27Kip1-immunopositive cells but did not fully re-established the sharp boundary between the outer and inner EGLs ([Fig. 7](#f0035){ref-type="fig"}). A scheme comparing GN proliferation in *Npc1^+/+^* and *Npc1^−/−^* EGLs, based on the findings of our study, is shown in [Fig. 8](#f0040){ref-type="fig"}.

Discussion {#s0020}
==========

This study shows that *Npc1* deficiency affects GN expansion during postnatal cerebellum development and that this leads first to a significant reduction of *Npc1^−/−^* IGL and finally of the entire cerebellar volume in *Npc1^−/−^* adult mice. The reduction of IGL size is also accompanied by a decrease of ML thickness, likely arising from the lower number of GN parallel fibers projecting to this area. Present observations agree with a recent report based on *in vivo* magnetic resonance that the volumes of several brain regions of *Npc1^−/−^* mice, including cerebellum, are smaller than those of age-matched wild-type mice since as early as 3 weeks of age (Totenhagen et al., personal communication).

In contrast to the approximately 16.5-day period of GN proliferation in the post-natal cerebellum of mice, we have found that GN precursors of *Npc1^−/−^* mice undergo a premature exit from the cell cycle, giving rise to a shortening of EGL duration in these mice. On the other hand, we have also observed that EGL thickness is normal until PN11 in *Npc1^−/−^* mice, meaning that the reduced proliferation of GN precursors does not affect the entire population of GN precursors, which apparently display timely proliferation and cell cycle exit patterns before PN11. In fact, under normal conditions, even in the presence of a consistent population of proliferating GN precursors, a fraction of these cells exit the cell cycle as early as PN4 ([@bb0010; @bb0085]), indicating that not all GN precursors exit the cell cycle at the same time. Therefore, our observations rule out the possibility that the development of the overall GN precursor population is defective in *Npc1^−/−^*, suggesting that only longer-lasting GN precursors undergo a reduction in proliferation activity. This conclusion is supported by the finding that the EGL of PN11 *Npc1^−/−^* is consistently enriched with post-mitotic, p27Kip1-positive GNs, distributed along the entire EGL, whereas the EGL of age-matched wild-type mice still hosts a significant fraction of dividing, p27Kip1-negative GNs in the outer EGL. The lack of a boundary between the oEGL and iEGL in PN11 *Npc1^−/−^* mice indicates that the function of locally-acting signals ([@bb0285]) is severely perturbed in the EGL of these mice, likely dysregulating the balance between GN\'s proliferation and exit from the cell cycle and accounting for the shorter-lasting EGL and the decreased GN\'s proliferation rate observed in these mice.

An additional, but not alternative, explanation for the shorter lasting EGL of *Npc1^−/−^* mice, is that molecular signals sustaining the proliferation of GN precursors become a limiting factor in *Npc1^−/−^*. For instance, the constant ratio of 175 GNs for each PC ([@bb0280]) led researchers to postulate that the number of GNs is somehow regulated by the number and the length of time PCs secrete Shh. Such a model, in which the reduced expansion of GNs is consequence of reduced availability of Shh, is in agreement with the reduced level of *Shh* transcripts that we measured in PN8 and PN12 *Npc1^−/−^* mice. This would also explain why only the proliferation activity of later-lasting GN precursors is affected. In fact, while there is no loss of PCs until after P35 ([@bb0210]), PCs of *Npc1^−/−^* mice display a significant cholesterol accumulation as early as at PN9 ([@bb0195]), making the hypothesis that the Shh signal becomes defective around this stage reasonable. However, in addition to Shh signal generation, mechanisms involved in Shh signal reception might also be involved as they are altered by cholesterol (reviewed in [@bb0075]), cholesterol being an essential component of lipid raft microdomains containing receptors and/or adhesion molecules. For instance, the hedgehog receptor Patched has recently been implicated in cholesterol transport ([@bb0035]). Key molecules controlling Shh-induced proliferation are expressed in a finely regulated spatio-temporal manner by a sub-population of GNs residing in a region of overlap between the oEGL and iEGL. Among these, TAG1 and F3, belonging to the contactin family, favor GN proliferation and cell cycle exit, respectively ([@bb0285]). In light of the complex spatial arrangement of GN subtypes at the level of the EGL, our finding that HPBCD treatment partially re-established the p27Kip1 expression pattern in *Npc1^−/−^* mice is worth of further investigation.

The very specific developmental defect identified by this study provides novel insights for a better understanding of the cerebellar neuropathology of NPC1 disease. In light of the relevance that the numerical matching between synaptic partners plays in circuit formation ([@bb0230]), our observations now raise the question of whether/how the reduction of GN number negatively affects the survival/differentiation of their synaptic partner, the PCs, and thus contributes to their final degeneration. However, although this possibility is attractive, at the moment it is not supported by the present observation that the reduction of GN number occurs similarly in both the anterior and posterior lobules rather than displaying the anterior-to-posterior gradient of PC degeneration typical of *Npc1^−/−^* mice ([@bb0210]). The interest in the potential contribution given to PC degeneration by a GN defect(s) has also been raised by a recent study showing that *Npc1^−/−^* mice display an enhanced parallel fiber to PC synaptic transmission and deficient long-term depression (LTD) ([@bb0240]). As a consequence, the increased glutamatergic transmission and LTD deficiency may cause PC chronic excitotoxicity, finally resulting in neurodegeneration.

Therapies available for NPC1 disease are limited. Among these, the treatment with the cyclic oligomers of 7-glucose HPBCDs was shown to rescue cholesterol defects and extend life in mouse models of the human Niemann--Pick C1 disease ([@bb0045; @bb0070; @bb0190]). This correction requires the endocytosis of the drug ([@bb0200]) and its action is quite similar to that of NPC2 ([@bb0140]). Here we have shown that a single subcutaneous HPBCD injection given at PN7 rescues the GN expansion defect of *Npc1^−/−^*, re-establishing normal patterns of EGL thickness and also increasing the total number of GNs compared to age-matched wild-type mice. *In vitro* studies ([@bb0170]) have also shown the efficacy of HPBCD in correcting the cholesterol storage abnormality in GNs. *In vivo*, a single HPBCD injection starting at PN7 *Npc1^−/−^* is a frequently used treatment, even though, more recently, the continuous intraventricular administration of HPBCDs in adult *Npc1^−/−^* mice has also been exploited resulting in the maintenance of cerebellar structure if started at day 7 ([@bb0015]). Interestingly, our results show that a single HPBCD treatment apparently counteracts the premature cell cycle exit of GN precursors, but has a limited efficacy in re-establishing the sharp boundary between the outer and inner EGL typical of the normally developing cerebellum. The ability of HPBCD to rescue the developmental defects of *Npc1^−/−^* GNs can be explained by several mechanisms. Sonic hedgehog (Shh) contains covalently-bonded cholesterol and either the generation or the transduction of this signaling could be defective ([@bb0105]). Cholesterol is needed for the transition of cells from G1 to S phase ([@bb0215]) and a relative deficiency of cholesterol at the correct sites in the dividing GNs could slow their divisions.

The findings of this study pose the question as to whether, besides the cerebellum, neuron generation is also affected in additional brain regions, either during embryonic or postnatal life, as also suggested by a study showing that *Npc1* deficiency impairs the self-renewal ability of neural stem cells ([@bb0290]). Increasing knowledge on this specific issue may contribute to the identification of novel strategies for NPC1 disease treatment in our species.
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![The cerebellum of adult *Npc1^−/−^* mice is reduced in size. (A) Gross morphological comparison of PN28 *Npc1^+/+^* and *Npc1^−/−^* mouse cerebella (brackets). Cx: cortex; Cb: cerebellum; Bs: brain stem. (B) Sagittal sections of cerebellar vermis from PN28 *Npc1^+/+^* and *Npc1^−/−^* mice, either untreated or treated with a single injection of HPBCD at PN7. Representative sections encompassing sagittal midline of vermis are shown in the figure. Superimposition of total vermis tracings indicates an overall size reduction in *Npc1^−/−^* mice compared to wild-type mice that was largely rescued by HPBCD treatment. (C) Histograms indicate total areas (mean ± SEM; 5--6 mice/group) measured on representative sections of *Npc1^+/+^* (empty bar), *Npc1^−/−^* (full bar) and HPBCD-treated *Npc1^−/−^* mice (dashed bar). Asterisk indicates statistically significant differences (\**p* \< 0.05). Scale bars indicate 2 mm (panel A) and 0.5 mm (panel B).](gr1){#f0005}

![Both anterior and posterior lobules of *Npc1^−/−^* cerebellum display a reduced size. (A) Parasagittal histological sections of PN28 mouse cerebella of [Fig. 1](#f0005){ref-type="fig"} were examined at higher magnification to evaluate the effect of genotype and/or HPBCD treatment on foliation and single lobule size. Representative sections are shown in the figure. *Npc1^−/−^* mice displayed an overall normal foliation pattern. However, the size of both anterior and posterior lobules was impaired and a single injection of HPBCD to PN7 *Npc1^−/−^* mice re-established the normal lobule size. (B) The extent of size reduction was measured in detail on lobule IV/V. Histograms indicate the total lobule and IGL and ML areas (mean ± SEM of all sections examined; 5--6 mice/group) measured on randomly selected parasagittal sections of *Npc1^+/+^* (empty bars), *Npc1^−/−^* (full bars) and HPBCD-treated *Npc1^−/−^* mice (dashed bars). Asterisks indicate statistically significant differences (\**p* \< 0.05; \*\**p* \< 0.005). Scale bar indicates 0.5 mm.](gr2){#f0010}

![*Npc1^−/−^* mice display reduced granule neuron density in the EGL that is rescued by the HPBCD treatment. (A,C) Cerebellar sections of PN11, PN14 *Npc1^+/+^*, and *Npc1^−/−^* mice, either untreated or treated with a single injection of HPBCD at PN7, were stained with Hoechst 33258. Representative sections are shown in the figure. Higher magnification fields of EGL base or crown of lobules II and X are shown on the right of low magnification fields. No major differences were detected at PN11. At PN14 however, the EGL of both anterior and posterior lobules of *Npc1^−/−^* mice was thinner than that of age-matched *Npc1^+/+^*, while HPBCD treatment fully rescued this phenotype. (B,D) Histograms represent granule neuron densities (mean ± SEM of all sections examined; 4--5 mice/group; 3--4 sections/mouse) determined in 100 μm^2^ regions of the crowns of the anterior (I--V) and posterior (VI--X) lobules of *Npc1^+/+^* (empty bars), *Npc1^−/−^* (full bars) and HPBCD-treated *Npc1^−/−^* (dashed bars) mice. Asterisks indicate statistically significant differences (\**p* \< 0.05; \*\**p* \< 0.005). Scale bars indicate 250 μm (panels) and 50 μm (inserts).](gr3){#f0015}

![*Npc1^−/−^* mice display reduced number of proliferating granule neurons that is rescued by the HPBCD treatment. (A) Histograms represent the number of BrdU-positive cells (mean ± SEM; 4--5 mice/group; 3--4 sections/mouse) determined in 100 μm^2^ regions corresponding to the bases and crowns of the anterior (I--V) and posterior (VI--X) lobules of *Npc1^+/+^* (empty bars), *Npc1^−/−^* (full bars) and HPBCD-treated *Npc1^−/−^* (dashed bars) mice. Asterisks indicate statistically significant differences (\**p* \< 0.05; \*\**p* \< 0.005). Note that the number of BrdU-positive GNs was significantly reduced in both crowns and fissures of the anterior cerebellar lobules of PN12 and PN14 *Npc1^−/−^* mice compared to age-matched *Npc1^+/+^* mice. (B) A representative field showing BrdU-positive cells (red) of fissure between lobules I and II of PN12 *Npc1^+/+^* (left), *Npc1^−/−^* (middle) and HPBCD-treated *Npc1^−/−^* mice (right). Note that HPBCD treatment re-established the normal number of proliferating cells. Scale bar indicates 50 μm.](gr4){#f0020}

![Cerebella of *Npc1^−/−^* and *Npc1^+/+^* display comparable numbers of apoptotic GNs. (A) Cerebellar sections of PN12, PN14 and PN28 *Npc1^+/+^* and *Npc1^−/−^* mice, either untreated or treated with a single injection of HPBCD at PN7, were stained with TUNEL. A representative field showing TUNEL-positive cells (red) of lobule II of PN14 *Npc1^+/+^* (top), *Npc1^−/−^* (middle) and HPBCD-treated *Npc1^−/−^* mice (bottom). Arrowheads indicate TUNEL-positive cells. Scale bar indicates 50 μm. (B) Histograms represent the number of TUNEL-positive cells (mean ± SEM; 4--5 mice/group; 3--4 sections/mouse) determined in 1 mm^2^ regions corresponding to the crown of lobule II of *Npc1^+/+^* (empty bars), *Npc1^−/−^* (full bars) and HPBCD-treated *Npc1^−/−^* (dashed bars) mice.](gr5){#f0025}

![*Npc1^−/−^* mice cerebella display a significantly reduced level of *Shh* transcripts. Semiquantitative real-time RT-PCR was performed on cerebella of PN8 and PN12 *Npc1^+/+^* (empty bars), *Npc1^−/−^* (full bars) and HPBCD-treated *Npc1^−/−^* (dashed bars). Histograms indicate the mean ± SEM of values obtained in three independent assays. Note that HPBCD re-established the normal level of *Shh* transcripts. Asterisks indicate statistically significant differences (\*\**p* \< 0.005).](gr6){#f0030}

![Cerebellar granule neurons of *Npc1^−/−^* mice exit the cell cycle earlier than those of wild-type mice. Cerebellar sections of PN11 *Npc1^+/+^* and *Npc1^−/−^* mice, either untreated or treated with a single injection of HPBCD at PN7 (3--4 mice/group; 3--4 sections/mouse) were immunostained with anti-p27Kip1 antibodies (brown). Nuclei were stained with methyl green. A representative field of fissure between lobules II and III is shown. Note the presence of scattered p27Kip1-positive GNs along the entire EGL of *Npc1^−/−^*. Low and high magnification of the same fields is shown in the right and left panels, respectively. The HPBCD treatment partially re-established the p27Kip1 expression pattern in *Npc1^−/−^* mice. Numbers (mean ± SEM) of p27Kip-positive GNs/100 μm^2^ were: *Npc1^+/+^*, 17.20 ± 0.81; *Npc1^−/−^*, 21.8 ± 0.79; HPBCD-treated *Npc1^−/−^*, 19.20 ± 0.95 (*Npc1^+/+^ vs Npc1^−/−^*, *p* = 0.03; HPBCD-treated *Npc1^−/−^ vs Npc1^+/+^*, *p* = 0.15; HPBCD-treated *Npc1^−/−^ vs Npc1^−/−^*, *p* = 0.09). oEGL: outer External Granule Layer; iEGL: inner External Granule Layer. Scale bars indicate 50 μm (left) and 25 μm (right).](gr7){#f0035}

![A model of defective GN proliferation in the *Npc1^−/−^*.](gr8){#f0040}
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